Talkmed Group 주식 주식분석 | 주식가격 | 뉴스 | 5G3.SI | SG2G61000003 |

날짜	Talkmed Group 주식 가격
	0.46 undefined
	0.46 undefined
	0.46 undefined
	0.46 undefined
	0.46 undefined
	0.46 undefined
	0.49 undefined
	0.50 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined
	0.45 undefined

날짜	Talkmed Group 매출	Talkmed Group EBIT	Talkmed Group 이익
2024e	67.03 백만 undefined	0 undefined	0 undefined
2023	83.79 백만 undefined	39.04 백만 undefined	32.18 백만 undefined
2022	76.6 백만 undefined	39.21 백만 undefined	30.55 백만 undefined
2021	60.75 백만 undefined	26.94 백만 undefined	25.12 백만 undefined
2020	62.14 백만 undefined	27.32 백만 undefined	22.77 백만 undefined
2019	75.92 백만 undefined	41.21 백만 undefined	35.75 백만 undefined
2018	61.28 백만 undefined	34.16 백만 undefined	28.91 백만 undefined
2017	61.36 백만 undefined	39.6 백만 undefined	32.04 백만 undefined
2016	68.91 백만 undefined	48.39 백만 undefined	37.39 백만 undefined
2015	65.72 백만 undefined	47.94 백만 undefined	37.33 백만 undefined
2014	63.17 백만 undefined	46.45 백만 undefined	38.53 백만 undefined
2013	56.27 백만 undefined	35.81 백만 undefined	28.21 백만 undefined
2012	51.86 백만 undefined	38.49 백만 undefined	31.98 백만 undefined
2011	49.14 백만 undefined	39.23 백만 undefined	32.6 백만 undefined
2010	48.34 백만 undefined	39.01 백만 undefined	32.43 백만 undefined

	매출	EBIT	이익
2010	48.34 백만 SGD	39.01 백만 SGD	32.43 백만 SGD
2011	49.14 백만 SGD	39.23 백만 SGD	32.6 백만 SGD
2012	51.86 백만 SGD	38.49 백만 SGD	31.98 백만 SGD
2013	56.27 백만 SGD	35.81 백만 SGD	28.21 백만 SGD
2014	63.17 백만 SGD	46.45 백만 SGD	38.53 백만 SGD
2015	65.72 백만 SGD	47.94 백만 SGD	37.33 백만 SGD
2016	68.91 백만 SGD	48.39 백만 SGD	37.39 백만 SGD
2017	61.36 백만 SGD	39.6 백만 SGD	32.04 백만 SGD
2018	61.28 백만 SGD	34.16 백만 SGD	28.91 백만 SGD
2019	75.92 백만 SGD	41.21 백만 SGD	35.75 백만 SGD
2020	62.14 백만 SGD	27.32 백만 SGD	22.77 백만 SGD
2021	60.75 백만 SGD	26.94 백만 SGD	25.12 백만 SGD
2022	76.6 백만 SGD	39.21 백만 SGD	30.55 백만 SGD
2023	83.79 백만 SGD	39.04 백만 SGD	32.18 백만 SGD
2024e	67.03 백만 SGD	0 SGD	0 SGD

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e
48	49	51	56	63	65	68	61	61	75	62	60	76	83	67
-	2.08	4.08	9.80	12.50	3.17	4.62	-10.29	-	22.95	-17.33	-3.23	26.67	9.21	-19.28
-	-	-	-	-	-	-	-	-	-	-	56.67	60.53	-	-
0	0	0	0	0	0	0	0	0	0	0	34	46	0	0
39	39	38	35	46	47	48	39	34	41	27	26	39	39	0
81.25	79.59	74.51	62.50	73.02	72.31	70.59	63.93	55.74	54.67	43.55	43.33	51.32	46.99	-
32	32	31	28	38	37	37	32	28	35	22	25	30	32	0
-	-	-3.13	-9.68	35.71	-2.63	-	-13.51	-12.50	25.00	-37.14	13.64	20.00	6.67	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1.31	1.31	1.31	1.31	1.3	1.31	1.31	1.31	1.31	1.31	1.32	1.33	1.33	1.33	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

10.46	12.36	16.75	24.89	50.9	49.56	64	71.05	73.99	80.7	79.43	82.16	81.24	89.9
5.25	5.56	6.04	6.83	9.01	9.17	6.43	8.37	8.31	11.42	9.5	8.37	11.02	10.87
10	10	0	570	130	480	266	269	407	845	792	637	806	571
0	0	0	0	0	0	0.06	0.17	0.28	0.86	1	0.77	1.28	1.42
0	0	0	70	41	103	178	273	648	610	584	486	444	335
15.72	17.93	22.79	32.36	60.07	59.31	70.93	80.13	83.64	94.43	91.31	92.42	94.78	103.1
0	0	0	0.05	0.03	0.52	0.51	0.67	4.23	8.74	6.17	8.51	10.08	9.66
0	0	0	0	0	8.64	5	4.54	3.4	2.89	7.11	7.44	3.7	2.81
0	0	0	0	0	15	14	0	0	0	0	410	606	222
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	9	4	18	25	0	0	0
0	0	0	0.05	0.03	9.17	5.53	5.22	7.64	11.64	13.31	16.36	14.38	12.69
15.72	17.93	22.79	32.41	60.1	68.49	76.46	85.36	91.27	106.07	104.62	108.79	109.17	115.79

0	0	0	2.31	22.27	22.27	22.27	22.27	22.27	22.44	23.91	24.51	25.12	25.81
0	0	0	0	0	0	0	0	0	0	0	0	0	0
7.52	10.12	12.1	10.49	27.53	34.04	41.3	50.69	51.99	60.96	59.32	65.11	63.74	63.9
0	0	0	0	0	0	0	-632	-495	-290	213	564	-148	413
0	0	0	0	0	0	0	0	0	0	0	0	0	0
7.52	10.12	12.1	12.8	49.8	56.32	63.58	72.33	73.77	83.1	83.43	90.18	88.71	90.12
1.25	0.89	0.76	8.05	1.33	1.51	1.74	0.3	0.52	1.28	0.4	0.63	0.8	1.77
0.35	0.23	3.42	4.48	0.91	1.28	2.02	2.56	3.94	3.35	4.15	3.4	4.68	7.45
6.6	6.69	6.52	7.09	8.06	8.3	8.57	8.65	8.28	10.36	11.07	8.25	12.04	13.33
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	1.77	1.79	1.98	1.85	4.73
8.2	7.81	10.7	19.62	10.3	11.1	12.32	11.5	12.74	16.77	17.41	14.25	19.38	27.28
0	0	0	0	0	0	0	0	0	2.12	2.69	4.49	5.23	4.45
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0.03	0.03	1.34	5.19	5.5	5.76	2.55	2.68	0
0	0	0	0	0	0.03	0.03	1.34	5.19	7.62	8.45	7.04	7.92	4.45
8.2	7.81	10.7	19.62	10.3	11.13	12.35	12.85	17.92	24.38	25.87	21.29	27.3	31.73
15.72	17.93	22.8	32.42	60.1	67.45	75.93	85.18	91.69	107.49	109.3	111.46	116.01	121.85

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
39	39	38	35	46	45	45	38	34	41	24	27	36	37
0	0	0	0	0	0	0	0	0	3	3	2	2	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0
-5	-7	-4	0	-18	-7	-3	-9	-5	-9	-3	-7	-5	0
0	0	0	0	0	2	2	1	0	0	6	0	2	1
0	0	0	0	0	0	0	0	0	0	0	0	0	0
6	6	6	7	7	8	8	8	7	6	5	9	5	7
33	31	34	35	27	40	44	30	30	35	31	23	37	41
0	0	0	0	0	0	0	0	-3	-2	-1	0	-4	0
0	0	0	0	0	-12	0	0	-3	-2	-8	-1	-5	0
0	0	0	0	0	-11	0	0	0	0	-6	-1	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	-1	-1	-2	-2	-2
0	0	0	0	0	0	0	0	0	0	0	0	0	0
-30	-30	-30	-27	-1	-29	-30	-23	-23	-27	-24	-18	-33	-31
0	0	0	0	-1	1	0	1	4	1	2	2	0	2
-30	-30	-30	-27	-21	-30	-30	-25	-28	-27	-25	-19	-31	-31
3	1	4	8	26	-1	14	7	2	6	-1	2	-1	9
33.49	31.9	34.39	35.64	27.53	39.81	44.56	30.46	26.15	33.76	29.32	22.39	32.97	41.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0

Talkmed Group 브루토마진	Talkmed Group 이익 마진	Talkmed Group EBIT-마진	Talkmed Group 이익 마진
2024e	61.31 %	0 %	0 %
2023	61.31 %	46.59 %	38.4 %
2022	61.31 %	51.18 %	39.88 %
2021	57.12 %	44.34 %	41.34 %
2020	61.31 %	43.97 %	36.64 %
2019	61.31 %	54.29 %	47.09 %
2018	61.31 %	55.74 %	47.18 %
2017	61.31 %	64.54 %	52.21 %
2016	61.31 %	70.21 %	54.26 %
2015	61.31 %	72.94 %	56.81 %
2014	61.31 %	73.54 %	61 %
2013	61.31 %	63.64 %	50.13 %
2012	61.31 %	74.22 %	61.67 %
2011	61.31 %	79.83 %	66.34 %
2010	61.31 %	80.7 %	67.09 %

	브루토마진	EBIT-마진	이익 마진
2010	61.31 %	80.7 %	67.09 %
2011	61.31 %	79.83 %	66.34 %
2012	61.31 %	74.22 %	61.67 %
2013	61.31 %	63.64 %	50.13 %
2014	61.31 %	73.54 %	61 %
2015	61.31 %	72.94 %	56.81 %
2016	61.31 %	70.21 %	54.26 %
2017	61.31 %	64.54 %	52.21 %
2018	61.31 %	55.74 %	47.18 %
2019	61.31 %	54.29 %	47.09 %
2020	61.31 %	43.97 %	36.64 %
2021	57.12 %	44.34 %	41.34 %
2022	61.31 %	51.18 %	39.88 %
2023	61.31 %	46.59 %	38.4 %
2024e	61.31 %	0 %	0 %

날짜	Talkmed Group 주당 매출	Talkmed Group EBIT 당 주식	Talkmed Group 주당 이익
2024e	0.05 undefined	0 undefined	0 undefined
2023	0.06 undefined	0.03 undefined	0.02 undefined
2022	0.06 undefined	0.03 undefined	0.02 undefined
2021	0.05 undefined	0.02 undefined	0.02 undefined
2020	0.05 undefined	0.02 undefined	0.02 undefined
2019	0.06 undefined	0.03 undefined	0.03 undefined
2018	0.05 undefined	0.03 undefined	0.02 undefined
2017	0.05 undefined	0.03 undefined	0.02 undefined
2016	0.05 undefined	0.04 undefined	0.03 undefined
2015	0.05 undefined	0.04 undefined	0.03 undefined
2014	0.05 undefined	0.04 undefined	0.03 undefined
2013	0.04 undefined	0.03 undefined	0.02 undefined
2012	0.04 undefined	0.03 undefined	0.02 undefined
2011	0.04 undefined	0.03 undefined	0.02 undefined
2010	0.04 undefined	0.03 undefined	0.02 undefined

	주당 매출	EBIT 당 주식	주당 이익
2010	0.04 SGD	0.03 SGD	0.02 SGD
2011	0.04 SGD	0.03 SGD	0.02 SGD
2012	0.04 SGD	0.03 SGD	0.02 SGD
2013	0.04 SGD	0.03 SGD	0.02 SGD
2014	0.05 SGD	0.04 SGD	0.03 SGD
2015	0.05 SGD	0.04 SGD	0.03 SGD
2016	0.05 SGD	0.04 SGD	0.03 SGD
2017	0.05 SGD	0.03 SGD	0.02 SGD
2018	0.05 SGD	0.03 SGD	0.02 SGD
2019	0.06 SGD	0.03 SGD	0.03 SGD
2020	0.05 SGD	0.02 SGD	0.02 SGD
2021	0.05 SGD	0.02 SGD	0.02 SGD
2022	0.06 SGD	0.03 SGD	0.02 SGD
2023	0.06 SGD	0.03 SGD	0.02 SGD
2024e	0.05 SGD	0 SGD	0 SGD

	주식 수량
2010	1.31 조. Aktien
2011	1.31 조. Aktien
2012	1.31 조. Aktien
2013	1.31 조. Aktien
2014	1.3 조. Aktien
2015	1.31 조. Aktien
2016	1.31 조. Aktien
2017	1.31 조. Aktien
2018	1.31 조. Aktien
2019	1.31 조. Aktien
2020	1.32 조. Aktien
2021	1.33 조. Aktien
2022	1.33 조. Aktien
2023	1.33 조. Aktien
2024e	1.33 조. Aktien

날짜	Talkmed Group 배당금
2024e	0.02 undefined
2023	0.02 undefined
2022	0.02 undefined
2021	0.01 undefined
2020	0.02 undefined
2019	0.02 undefined
2018	0.02 undefined
2017	0.02 undefined
2016	0.02 undefined
2015	0.02 undefined
2014	0.02 undefined

	배당금	배당금 (추정)
2010	0 SGD	0 SGD
2011	0 SGD	0 SGD
2012	0 SGD	0 SGD
2013	0 SGD	0 SGD
2014	0.02 SGD	0 SGD
2015	0.02 SGD	0 SGD
2016	0.02 SGD	0 SGD
2017	0.02 SGD	0 SGD
2018	0.02 SGD	0 SGD
2019	0.02 SGD	0 SGD
2020	0.02 SGD	0 SGD
2021	0.01 SGD	0 SGD
2022	0.02 SGD	0 SGD
2023	0.02 SGD	0 SGD
2024e	0 SGD	0.02 SGD

날짜	Talkmed Group 배당률
2024e	92.74 %
2023	97.19 %
2022	104.44 %
2021	76.6 %
2020	110.53 %
2019	75.95 %
2018	96.91 %
2017	78.07 %
2016	80.58 %
2015	82.54 %
2014	55.03 %
2013	97.19 %
2012	97.19 %
2011	97.19 %
2010	97.19 %

	배당률
2010	97.19 %
2011	97.19 %
2012	97.19 %
2013	97.19 %
2014	55.03 %
2015	82.54 %
2016	80.58 %
2017	78.07 %
2018	96.91 %
2019	75.95 %
2020	110.53 %
2021	76.6 %
2022	104.44 %
2023	97.19 %
2024e	92.74 %

%-지분	이름	주식	변경
64.69416 %	Ladyhill Holdings Pte. Ltd.	858,912,000	0
7.48390 %	Khoo (Kei Siong)	99,360,000	0
7.40075 %	Teo (Cheng Peng)	98,256,000	0
3.57564 %	Lim (Hong Liang)	47,472,000	0
0.47359 %	See (Hui Ti)	6,287,593	123,191
0.37201 %	Lim (Bee Kok)	4,939,000	0
0.16299 %	Quek (Hong Hui Richard)	2,163,951	664,529
0.15215 %	Lai (Jason Justin)	2,020,000	0
0.14754 %	Zee (Ying Kiat)	1,958,773	137,094
0.12051 %	Chan (Jin Hoe)	1,600,000	0
0.11298 %	Ng (Lin Chieh Kelvin)	1,500,000	0
0.11298 %	Tan (Yii Hsien Barnabas)	1,500,000	0
0.11298 %	Foo (Mei Ping)	1,500,000	0
0.11129 %	Diong (Colin Phipps)	1,477,490	1,477,490
0.10470 %	Sng (Su Ying Marian)	1,390,000	0
0.09512 %	Thng (Yongxian)	1,262,800	-384,300
0.09168 %	Wong (Chiung Ing)	1,217,216	1,217,216
0.08421 %	Kok (Jaan Yang)	1,118,079	-58,916
0.08288 %	Chandra Das S O Rajagopal Sitaram	1,100,300	0
0.02260 %	Leong (Ching Ching)	300,000	0
0.00452 %	Tan (Khai Tong)	60,000	60,000

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Citigroup	공급업체고객	-0,17	0,33	0,12	0,34	0,63
UOB-Kay Hian Holdings	공급업체고객	-0,29	0,65	0,18	0,21	-0,19

What values and corporate philosophy does Talkmed Group represent?

The values and corporate philosophy of Talkmed Group Ltd encompass a strong commitment to excellence in healthcare services. With a focus on patient-centric care, Talkmed Group Ltd strives to provide high-quality, comprehensive medical solutions. The company emphasizes professionalism, integrity, and innovation in its operations, aiming to deliver the best possible outcomes for patients. With a dedicated team of medical professionals and cutting-edge technology, Talkmed Group Ltd continuously seeks to enhance its services and expand its expertise, all while maintaining a patient-centered approach.

In which countries and regions is Talkmed Group primarily present?

Talkmed Group Ltd is primarily present in Singapore.

What significant milestones has the company Talkmed Group achieved?

Talkmed Group Ltd has achieved several significant milestones in its history. The company has successfully established itself as a leading provider of integrated oncology services in Singapore and the region. Talkmed Group Ltd has received numerous accolades and recognition for its dedication to delivering high-quality and comprehensive cancer care. The company has also built strong partnerships with key medical institutions and renowned oncologists, cementing its position as a trusted and reliable player in the field. With its commitment to innovation and patient-centric care, Talkmed Group Ltd continues to make strides in the oncology industry, driving positive outcomes for patients and their families.

What is the history and background of the company Talkmed Group?

Talkmed Group Ltd, a leading healthcare provider in Singapore, has an intriguing history and background. Established in 2005, the company was founded by Dr. Ang Peng Tiam, a renowned medical oncologist. Talkmed Group Ltd primarily focuses on the provision of specialized medical services, particularly in the field of oncology. Building upon their commitment to quality care, Talkmed Group Ltd has partnered with numerous local and international hospitals, enabling them to expand their reach and offer exceptional healthcare services to a broader patient base. With their team of highly qualified healthcare professionals and state-of-the-art facilities, Talkmed Group Ltd continues to make significant contributions to the medical industry, solidifying their position as a trusted name in healthcare.

Who are the main competitors of Talkmed Group in the market?

The main competitors of Talkmed Group Ltd in the market include Raffles Medical Group, Singapore Medical Group, and Q&M Dental Group.

In which industries is Talkmed Group primarily active?

Talkmed Group Ltd is primarily active in the healthcare industry.

What is the business model of Talkmed Group?

The business model of Talkmed Group Ltd involves providing integrated healthcare services, specializing in cancer treatment and medical oncology. As a leading medical group in Singapore, Talkmed focuses on delivering personalized and comprehensive care to patients, employing a multidisciplinary approach. The company collaborates with other healthcare providers and maintains close relationships with top hospitals and medical professionals. Talkmed offers a range of services such as clinical research, telemedicine, oncology training, and consultancy services. By combining advanced medical technology, research, and expertise, Talkmed Group Ltd aims to improve patient outcomes and enhance the quality of cancer care.

Talkmed Group 2024의 P/E 비율은 얼마입니까?

Talkmed Group의 P/E 비율은 0입니다.

Talkmed Group 2024의 KUV는 얼마입니까?

Talkmed Group의 P/S 비율은 9.04입니다.

Talkmed Group의 AlleAktien 품질 점수는 얼마인가요?

Talkmed Group에 대한 AlleAktien 품질 점수는 7/10입니다.

Talkmed Group 2024의 매출은 얼마인가요?

예상되는 Talkmed Group 매출은 67.03 백만 SGD입니다.

Talkmed Group 2024의 이익은 얼마인가요?

Talkmed Group의 현재 이익을 계산할 수 없습니다.

Talkmed Group은 무엇을 하나요?

The Talkmed Group Ltd is a publicly traded company based in Singapore. It operates in various areas of medicine, providing both clinical and diagnostic services. In addition, it specializes in the development of medical devices and technologies. Clinical services Talkmed is one of the leading cancer specialists in Asia, offering a wide range of clinical services including oncology, hematology, surgery, radiation therapy, cardiology, and neurology. These services are provided by experienced doctors and specialists who work closely with patients to achieve the best treatment outcomes. Diagnostic services Talkmed Group Ltd offers specialized diagnostic services such as pathology, radiology, and nuclear medicine. These services are crucial for detecting diseases and are therefore an important preventative measure. Development of medical devices and technology The company also specializes in developing medical devices and technologies to improve clinical and diagnostic services. One of its key products is the OncoSweep technology, which enables doctors to quickly and effectively detect cancer cells and tissues. Other products Talkmed also offers pharmaceutical products, either developed by third parties or produced by themselves. These products are used in combination with clinical and diagnostic services to provide better treatment outcomes for patients. Business model Talkmed Group Ltd's business model is based on providing high-quality clinical and diagnostic services. They strive to offer the best medical care by utilizing the latest technologies and procedures and employing experienced and qualified professionals. Talkmed Group earns its revenue by billing patients and insurance companies for the services provided. However, the company also aims to expand its presence in the market by participating in or acquiring other companies. It also has a strong presence in Southeast Asia, where there is great potential in the healthcare industry. In summary, Talkmed Group Ltd's business model is focused on providing high-quality clinical and diagnostic services to improve patients' lives. The company also has a strong commitment to developing new medical devices and technologies to enhance diagnostic accuracy and the effectiveness of clinical services. Talkmed Group Ltd will continue to grow in the future as there is a high demand in the healthcare industry.